Skip to main content
Equibles

EOCN · Galmed Pharmaceuticals Ltd. · Webcasts, Transcripts & Audio

Track EOCN — free

Use EOCN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EOCN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.39 -0.09 (-3.63%) At close · Nov 12 Q4 2021 earnings call transcript
Rebalance outlook locked
Market Cap
$2.55M
Shares
1.07M
Volume · Nov 12 3434 Avg daily vol (53 sessions) 18.38K

Galmed Pharmaceuticals Ltd. Webcasts

Earnings calls, investor updates, investor days and conferences for Galmed Pharmaceuticals Ltd. (EOCN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)

Embed Galmed Pharmaceuticals Ltd. earnings calls on your site

Pick a widget, match your page, then paste the code where it should appear.

Widget
Theme
Accent color Pro

Match your site's colors with Pro. The Equibles credit stays on every plan.

Embed code 

                    
The widget credits Equibles and keeps the link below it on every plan.

                

            


            

                Preview
                
            

        

        
    

    




    
    
    


        

    

        

            

                Key facts
                    
                        CIK
                        1595353
                    
                    
                        CUSIP
                        M47238205
                    
                    
                        13F (30d)
                        5 filings
                        5 filers
                    
                    
                    
                         Visit website
                        
                    
                    
                         Investor relations